Table 2.
Treatment outcomes
Outcome | Short-course group (n = 33) | Long-course group (n = 19) | p-value |
---|---|---|---|
Treatment failure—n (%) | 5 (15.2%) | 3 (15.8%) | 1.000 |
C. Difficile infection within 30 days—n (%) | 0 (0%) | 0 (0%) | |
Hospital readmission within 30 days—n (%) | 1 (3.0%) | 6 (31.6%) | .007 |
UTI-related readmission—n (%) | 0 (0%) | 0 (0%) | |
Telephone encounters within 30 days of discharge—n (%) | 13 (39.4%) | 9 (47.4%) | .575 |
Duration of IV beta-lactam treatment (days) – median (IQR) | 3 (3–3) | 3 (2–4) | .312 |
Total antibiotic duration (days) – median (IQR) | 3 (3–3) | 6 (5–7) | < .001 |
Discharge antibiotics prescribed—n (%) | 2 (6.1%) | 9 (47.4%) | < .001 |
Hospital length of stay (days) – median (IQR) | 3.66 (2.42–8.32) | 3.94 (2.92–6.66) | .932 |